NextCell Pharma in Flemingsberg has published extremely promising results from its clinical studies of drug candidate ProTrans for the treatment of type 1 diabetes. A study is now being carried out with the aim of examining its efficacy in children and young people.
Foundation Flemingsberg Science is to join the Swedish Incubators & Science Parks network, a collaboration that will accelerate the development of Flemingsberg’s internationally competitive innovation environment.
The “Kodkuporna” programme started in Flemingsberg in May, a project that gives children and young people the opportunity to try their hand at programming. Students from KTH and Södertörn University mentor middle school students from Vistaskolan in play-based learning.
Developing Advanced Therapy Medicinal Products (ATMPs) is a growing field. Karolinska Institute and Karolinska University Hospital have unique facilities and expertise in this field.
The pre-GMP laboratory at Karolinska Institutet gives companies the opportunity to develop products, drugs and treatments. It is hoped for an increased interest from the industry to cooperate. Professor Matti Sällberg, head of the pre GMP unit, talks more about how this can be helpful early in the development.
Flemingsberg Science Foundation has recently developed a new strategic direction with clear goals for the coming years. The focus of the plan is on co-ordinating and strengthening efforts to attract more companies to Flemingsberg.
Flemingsberg Science is an active part of Stockholm Life Tech. It develops new opportunities for collaboration and co-operation related to Flemingsberg’s research and innovation infrastructure.
The innovation nodes in the Stockholm region are key platforms for collaboration that bridge gaps in innovation ecosystems. Additional resources are now needed to strengthen inter-nodal co-operation.
A Working Lab (AWL) Innomedicum on Solna Campus is home to start-ups in life science, offering office space and lab facilities to new companies. We had the chance to speak to Åsa Johansson, newly appointed head of A Working Lab, Akademiska Hus, to find out more.
Karolinska Cell Therapy Center (KCC) is a core facility whose function is to facilitate the development of new treatments with advanced therapy drugs (ATMP) and cells for transplant. Pontus Blomberg, operations manager at KCC, tells us more!